Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin Treatment in Sepsis and Septic Shock
NCT02647554Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2016
- Primary completion
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of ulinastatin in sepsis, septic shock, sponsored by Peking Union Medical College Hospital. Started Dec 2016; status: completed.
02
Drugs
ulinastatin
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT02647554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02647554.